MindWalk Holdings Corp. (HYFT)

Market Cap	61.17M +499.7%
Revenue (ttm)	19.02M +49.5%
Net Income	-21.29M
EPS	-0.50
Shares Out	46.69M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,053,670
Open	1.200
Previous Close	1.280
Day's Range	1.200 - 1.490
52-Week Range	0.316 - 3.246
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 12, 2026

About HYFT

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 202...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jan 3, 2017
• Employees: 102
• Stock Exchange: NASDAQ
• Ticker Symbol: HYFT
• Website: https://www.mindwalkai.com

Financial Performance

In fiscal year 2025, MindWalk Holdings's revenue was 24.52 million, an increase of 0.01% compared to the previous year's 24.52 million. Losses were -30.23 million, 15.8% more than in 2024.

Financial numbers in CAD